1988
DOI: 10.1021/ja00218a062
|View full text |Cite
|
Sign up to set email alerts
|

Silylation-mediated oxidation of 4-aza-3-ketosteroids with DDQ proceeds via DDQ-substrate adducts

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
43
0
3

Year Published

2003
2003
2017
2017

Publication Types

Select...
5
2
1

Relationship

2
6

Authors

Journals

citations
Cited by 89 publications
(46 citation statements)
references
References 0 publications
0
43
0
3
Order By: Relevance
“…4 Their preparation typically requires two or more steps 5-7 and/or the use of stoichiometric reagents, such as 2-iodoxybenzoic acid (IBX) 8,9 or 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ). 10 Catalytic methods for aerobic dehydrogenation of ketones to enones would provide appealing, atom-economical alternatives to these stoichiometric method.…”
mentioning
confidence: 99%
“…4 Their preparation typically requires two or more steps 5-7 and/or the use of stoichiometric reagents, such as 2-iodoxybenzoic acid (IBX) 8,9 or 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ). 10 Catalytic methods for aerobic dehydrogenation of ketones to enones would provide appealing, atom-economical alternatives to these stoichiometric method.…”
mentioning
confidence: 99%
“…chapter 1 I noted the unusual silylation-mediated [bistrimethylsilyltrifluoroacetamide (BSTFA)] DDQ oxidation of a lactam to form its unsaturated analog proceeding via a substrate-DDQ adduct followed by a thermal loss of the hydroquinone (Figure 1.8). This chemistry forms the nucleus of the finasteride manufacturing process, 14 but the story from the bench to the pilot plant during the early development of this product is much more complex than the scheme indicates. We have all delighted in telling this episode over the years in our finasteride presentations.…”
Section: Finasteride: Can the Engineers Actually Be Right?mentioning
confidence: 99%
“…These observations formed the core of a very practicable approach to finasteride, once again tying together solid new science with hardcore process research. (24,25) During the 90's we foresaw a need for the enantiomers of 21, one of our lead LTD 4 antagonists. The compound was proceeding in development as the racemate, despite the fact that as early as 1960 we were proceeding forward with single enantiomer drugs such as methyldopa, rather than racemates.…”
Section: % Yieldmentioning
confidence: 99%